Lek's Revenues to Top EUR 551m This Year

Ljubljana, 9 November - Drug maker Lek is expected to up revenues by about 34 percent this year, to SIT 134bn (EUR 551m). "We will achieve this goal despite a weak dollar," Lek chairman Metod Dragonja said in an interview for STA, adding that the effects of the revamped drug-prescription system will also their mark on the company's balance sheet.